Tempus AI's growth is fueled by data services and acquisitions, despite financial risks. Key Q2 results may shape its path to ...

With a trading volume of 7,459,075, the price of TEM is down by -4.37%, reaching $59.29. Current RSI values indicate that the stock is is currently neutral between overbought and oversold. Next ...

Tempus AI and NVIDIA are both actively working at the intersection of AI and healthcare. Tempus AI, while advancing precision ...

Tempus AI's growth in precision oncology drives an 80% revenue boost by 2025. Click here to find out why I rate TEM stock a ...

While this signals stretched valuations in the market, not all artificial intelligence (AI) stocks joined the frenzy. There ...

Former House Speaker Nancy Pelosi said back in 2022 the Senate would soon vote on a bill banning members of Congress from trading individual stocks. Roughly three years later, Pelosi is no ...

Tempus AI is a growth stock that is down 31% from all-time highs. Here's why TEM AI stock could be a part of your TFSA ...

AI Stocks are leading the next wave of tech innovation, from chipmakers to healthcare and voice tech.SoundHound stock has gained over 125% in 202 ...

TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.

Given the company’s popularity among hedge funds and the bullish sentiment surrounding it, Tempus AI, Inc. (NASDAQ:TEM) makes ...

Following closely was ARK’s investment in Tempus AI Inc (TEM), where the firm bought 158,051 shares across its ARKK and ARKG ETFs, totaling $8,833,470. This purchase continues a recent trend of ARK ...

AI could inject an additional $461 billion into the healthcare sector by 2035, according to Accenture, as it races past the ...